Parvovirus B19, DNA, Amniotic Fluid
Use
This test is intended to be used as an aid in the diagnosis of infections caused by parvovirus B19.
Special Instructions
Not provided.
Limitations
This test was developed and its performance characteristics determined by LabCorp Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes and should not be regarded as investigational or research. Results should be interpreted in the context of clinical findings and other laboratory tests.
Methodology
PCR-based (Real-time PCR)
Biomarkers
Parvovirus B19
Microorganism
LOINC Codes
- 9571-1 - B19V DNA Spec Ql NAA+probe
Result Turnaround Time
4-6 days
Related Documents
For more information, please review the documents below
Specimen
Amniotic Fluid
Volume
0.5 mL
Minimum Volume
0.2 mL
Container
Sterile plastic conical tube
Collection Instructions
Amniotic fluid should not be centrifuged.
Storage Instructions
Freeze (preferred) or refrigerate
Causes for Rejection
Quantity not sufficient for analysis; gross specimen contamination; specimen too old; leaking or broken tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 7 days |
| Frozen | 90 days |
Other tests from different labs that may be relevant